Evaluation of serum and urinary angiogenic factors in patients with endometriosis

American Journal of Reproductive Immunology

Volumn 58, Issue 6, 2007, Pages 497-504

  Cho, Si Hyun ^a   Oh, Yoon Jin ^a   Nam, Anna ^a   Kim, Hye Yeon ^a   Park, Joo Hyun ^b   Kim, Jae Hoon ^a   Park, Ki Hyun ^a   Cho, Dong Je ^a   Lee, Byung Seok ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Endometriosis; Serum; SFlt 1; TNF ; Urine VEGF

Indexed keywords

ANGIOGENIC FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CREATININE URINE LEVEL; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; ENDOMETRIOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; LAPAROSCOPY; LAPAROTOMY; MAJOR CLINICAL STUDY; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL;

ADULT; ANGIOGENESIS INDUCING AGENTS; ENDOMETRIOSIS; FEMALE; HUMANS; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 36048993203     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2007.00535.x     Document Type: Article

References (28)

1. Taylor RN, Levoric DI, Mueller MD: Angiogenic factors in endometriosis. Ann N Y Acad Sci 2002; 955:90-100.
2. Gagne D, Page M, Robitaille G, Hugo P, Gosselin D: Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum Reprod 2003; 18:1674-1680.
3. McLaren J: Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update 2000; 48:81-98.
4. Fasciani A, D'Ambrogio G, Bocci G, Luisi S, Artini PG, Genazzani AR: Vascular endothelial growth factor and interleukin-8 in ovarian cystic pathology. Fertil Steril 2001; 75:1218-1221.
5. Bedaiwy MA, Falcone T, Sharma RK, Goldberg JM, Attaran M, Nelson DR, Agarwal A: Prediction of endometriosis with serum and peritoneal fluid markers: A prospective controlled trial. Hum Reprod 2002; 17:426-431.
6. Steff A, Gagne D, Page M, Rioux A, Hugo P, Gosselin D: Serum concentrations of insulin-like growth factor-1, soluble tumor necrosis factor receptor-1 and angiogenin in endometriosis patients. Am J Reprod Immunol 2004; 51:166-173.
7. Darai E, Detchev R, Hugol D, Quang NT: Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours. Hum Reprod 2003; 18:1681-1685.
8. Aref S, El Sherbiny M, Goda T, Fouda M, Al Askalany H, Abdalla D: Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient outcome. Hematology 2005; 10:131-134.
9. Ilhan N, Ilhan N, Deveci F: Functional significance of vascular endothelial growth factor and its receptor (receptor-1) in various lung cancer types. Clin Biochem 2004; 37:840-845.
10. Kumar H, Heer K, Greenman J, Kerin MJ, Monson JR: Soluble FLT-1 is detectable in the sera of colorectal and breast cancer patients. Anticancer Res 2002; 22:1877-1880.
11. Iwabe T, Harada T, Tsudo T, Nagano Y, Tanikawa M, Terakawa N: Tumor necrosis factor-a promotes proliferation of the endometriotic stromal cells by inducing interleukin-8 gene and protein expression. J Clin Endocrinol Metab 2000; 85:824-829.
12. Ulukus M, Ulukus EC, Seval Y, Zheng W, Arici A: Expression of interleukin-8 receptors in endometriosis. Hum Reprod 2005; 20:794-801.
13. Dvorak HF: Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 2002; 20:4368-4380.
14. Matsumoto K, Kanmatsuse K: Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephritic syndrome. Clin Nephrol 2001; 55:269-274.
15. Kitamoto Y, Matsuo K, Tomita K: Different response of urinary excretion of VEGF in patients with chronic and acute renal failure [letter]. Kidney Int 2001; 59:385-386.
16. Buhimschi CS, Norwitz ER, Funai E, Richman S, Guller S, Lockwood CJ, Buhimschi IA: Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia. Am J Obstet Gynecol 2005; 192:734-741.
17. Rivera M, Talens-Visconti R, Sirera R, Bertomeu V, Salvador A, Cortez R, Burgos FG, Climent V, Paya R, Martinez-Dolz L, Sancho-Tello MJ, Gonzalez-Molina A: Soluble TNF-alpha and interleukin-6 receptors in the urine of heart failure patients. Their clinical value and relationship with plasma levels. Eur J Heart Fail 2004; 6:877-882.
18. American Society for Reproductive Medicine: Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997; 67:817-821.
19. Robertson D, Selleck K, Suikkari AM, Hurley V, Moohan J, Healy D: Urinary vascular endothelial growth factor concentrations in women undergoing gonadotropin treatment. Hum Reprod 1995; 10:2478-2482.
20. Xavier P, Belo L, Beires J, Rebelo I, Martinez-de-Oliveira J, Lunet N, Barros H: Serum levels of VEGF and TNF-alpha and their association with C-reactive protein in patients with endometriosis. Arch Gynecol Obstet 2006; 273:227-231.
21. Artini PG, Cristello F, Monti M, Cela V, Battaglia C, D'Ambrogio G, Genazzani AR: Vascular endothelial growth factor and its soluble receptor in ovarian pathology. Gynecol Endocrinol 2005; 21:50-56.
22. McIlhenny C, George WD, Doughty JC: A comparison of serum and plasma levels of vascular endothelial growth factor during the menstrual cycle in healthy female volunteers. Br J Cancer 2002; 86:1786-1789.
23. Potlog-Nahari C, Stratton P, Winkel C, Widra E, Sinaii N, Connors S, Nieman LK: Urine vascular endothelial growth factor-A is not a useful marker for endometriosis. Fertil Steril 2004; 81:1507-1512.
24. Krussel JS, Casan EM, Raga F, Hirchenhain J, Wen Y, Huang HY, Bielfeld P, Polan ML: Expression for mRNA for VEGF transmenbraneous receptors Flt-1 and KDR, and the soluble receptor sflt in cycling human endometrium. Mol Hum Reprod 1999; 5:452-458.
25. Clark DE, Smith SK, He Y, Day KA, Licence DR, Corps AN, Lammoglia R, Charnock-Jones DS: A vascular endothelial growth factor antagonist is produced by human placenta and released into the maternal circulation. Biol Reprod 1998; 59:1540-1548.
26. Kendall RL, Wang G, Thomas KA: Identification of a natural soluble form of the vascular endothelial growth factor response, FLT-1 and its heterodimerization with KDR. Biochem Biophys Res Commun 1996; 226:324-328.
27. Hull ML, Charncock-Jones DS, Chan CLK, Bruner-Tran KL, Osteen KG, Tom BDM, Fan TPD, Smith SK: Antiangiogenic Agents Are Effective Inhibitors of Endometriosis. J Clin Endocrinol Metab 2003; 88:2889-2899.
28. Yamaguchi T, Bando H, Mori T, Takahashi K, Matsumoto H, Yasutome M, Weich H, Toi M: Overexpression of soluble vascular endothelial growth factor receptor 1 in colorectal cancer: Association with progression and prognosis. Cancer Sci 2007; 98:405-410.